Related posts
2 Big Technology Stocks That Are BackStocks sink, oil risesU.S markets close down for the week, TSX steadierThis summary was created by AI, based on 3 opinions in the last 12 months.
DocuSign (DOCU-Q) has been recognized by several experts as a company with promising earnings potential and strong free cash flow characteristics. Despite the struggles faced during the pandemic, experts believe it now trades at a fair valuation, with a price-to-earnings ratio around 16 and a free cash flow yield of 8%. There is a notable consensus about the capability of its management, which is characterized by a conservative approach to forecasts, often leading to positive earnings surprises. While growth has plateaued to some extent, DocuSign retains its dominance in the market and remains an attractive acquisition target. Overall, the sentiments are cautiously optimistic, positioning the stock for continued stability and potential growth.
Their Q2 earnings beat. A pandemic darling that then crashed. But now it trades at a fair valuation and strong free cash flow. She bought it last September is up 35%. Trades at 16x PE and has a 8% free cash flow yield. Great managers who underpromise, so they will beat their quarter. Has real secular growth.
It has maxed out to a large degree on the growth side. It is still dominant in the space and could be an acquisition target.
Dominates this business, but ADBE has entered the space. Stock's gone sideways. Software is not unique, and competition will show up. Perhaps a bigger player like MSFT would buy it and incorporate the technology.
Has a new CEO since last year and he's aggressively cut costs. Last month, they reported one of their best quarters in years, but shares didn't get any traction.
Likes and uses its software, but it's still too close to its post-Covid hangover to buy. There are too many competitors, too.
Docusign is a American stock, trading under the symbol DOCU-Q on the NASDAQ (DOCU). It is usually referred to as NASDAQ:DOCU or DOCU-Q
In the last year, 3 stock analysts published opinions about DOCU-Q. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Docusign.
Docusign was recommended as a Top Pick by on . Read the latest stock experts ratings for Docusign.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered Docusign In the last year. It is a trending stock that is worth watching.
On 2025-03-25, Docusign (DOCU-Q) stock closed at a price of $89.39.
Decent earnings lie ahead. Has a 5.5% free cash flow yield.